These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16532637)

  • 21. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Ivins BE; Welkos SL; Knudson GB; Little SF
    Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
    Oscherwitz J; Yu F; Cease KB
    J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
    Shakya KP; Hugh-Jones ME; Elzer PH
    Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
    [No Abstract]   [Full Text] [Related]  

  • 28. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine.
    Kim YH; Kim KA; Kim YR; Choi MK; Kim HK; Choi KJ; Chun JH; Cha K; Hong KJ; Lee NG; Yoo CK; Oh HB; Kim TS; Rhie GE
    Proteomics; 2014 Jan; 14(1):93-104. PubMed ID: 24273028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthrax vaccines: a development update.
    Little SF
    BioDrugs; 2005; 19(4):233-45. PubMed ID: 16128606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines against anthrax based on recombinant protective antigen: problems and solutions.
    Kondakova OA; Nikitin NA; Evtushenko EA; Ryabchevskaya EM; Atabekov JG; Karpova OV
    Expert Rev Vaccines; 2019 Aug; 18(8):813-828. PubMed ID: 31298973
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.
    Chen Z; Schneerson R; Lovchik JA; Dai Z; Kubler-Kielb J; Agulto L; Leppla SH; Purcell RH
    Clin Vaccine Immunol; 2015 Aug; 22(8):902-8. PubMed ID: 26041039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.
    Barnard JP; Friedlander AM
    Infect Immun; 1999 Feb; 67(2):562-7. PubMed ID: 9916059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.
    Rivera J; Cordero RJ; Nakouzi AS; Frases S; Nicola A; Casadevall A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19002-7. PubMed ID: 20956325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC; An HJ; Yu YZ; Xu Q
    Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.
    Singh Y; Ivins BE; Leppla SH
    Infect Immun; 1998 Jul; 66(7):3447-8. PubMed ID: 9632621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of immunity and allergy after vaccination with dry combined anthrax vaccine].
    Shevtsov AN; Darmov IV; Saîtseva GA; Borovskoî DV; Menovshchikov VA; Kunof VK; Gracheva TA
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):51-3. PubMed ID: 18038547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A; Tonello F; Garofolo G; Muraro L; Carattoli A; Adone R; Montecucco C
    Vaccine; 2008 Oct; 26(45):5684-8. PubMed ID: 18775462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.